Your session is about to expire
← Back to Search
LGBTQ-Inclusive Care Training for Alzheimer's Disease (MILLS Trial)
N/A
Recruiting
Led By Tetyanna Shippee, PhD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether training the long-term care workforce in sexual and gender minority culturally responsive care improves care for patients with Alzheimer's Disease and Alzheimer's Disease Related Dementia.
Who is the study for?
This trial is for licensed Minnesota nursing or housing services staff who manage or supervise at least 5 people. They must be willing to review policies and environment now and in 6 months, and speak/read English. It's not for those unable to communicate in English.
What is being tested?
The study compares two training programs aimed at improving care for LGBTQ seniors with Alzheimer's or related dementia: an in-person program (TTS) versus an online version (eTTS), against a waitlist control group, to see which is more effective.
What are the potential side effects?
Since this trial involves educational training programs rather than medical treatments, traditional physical side effects are not applicable. Participants may experience the time commitment as a potential burden.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Competence in SGM Care
Environment change
Skills assessment
Secondary study objectives
Health care empathy
SGM attitudes
SGM knowledge
+1 moreOther study objectives
Agency demographics
Discrimination experience at work
SGM estimate
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Training to Serve online training (eTTS)Experimental Treatment1 Intervention
Participants are provided a unique identifier to access the online website. The opening page welcomes them to the study, then directs them to the chunked consent materials and baseline survey. As soon as they have completed this, they receive access to the intervention, which for management is expected to take 1-2 hours and for staff, 30-45 minutes (i.e., the online equivalent of 3-4 and 1 hour, respectively). After completion of the required modules, participants receive access to the optional modules as well as the posttest survey to evaluate the training. Once the post-test is complete, they are thanked for their involvement and informed they will receive an e-mail to access a follow-up survey in six months' time.
Group II: Training to Serve (TTS) in person trainingExperimental Treatment1 Intervention
Participants are provided access to the pretest one week before the training. On the day of training, when the trainers arrive, participants have a final opportunity to complete the baseline survey before the intervention. Tablets will be available to complete pre- and post- surveys. The training for management takes 3-4 hours, and for staff, one hour. For consistency and feasibility, both trainings are conducted by the same trainers at the same visit. Immediately after the intervention, participants complete the post-intervention seminar evaluation assessing knowledge and attitudes/comfort in serving SGM clients.
Group III: Waitlist controlActive Control1 Intervention
Participants complete the baseline survey, then they receive a note thanking them for completing all activities and informing them the intervention will be available in 6 months' time.
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,785 Previous Clinical Trials
28,183,976 Total Patients Enrolled
292 Trials studying Dementia
23,634,113 Patients Enrolled for Dementia
University of MinnesotaLead Sponsor
1,427 Previous Clinical Trials
1,619,813 Total Patients Enrolled
17 Trials studying Dementia
5,050 Patients Enrolled for Dementia
Tetyanna Shippee, PhDPrincipal InvestigatorUniversity of Minnesota
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to review policies and environment now and in 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: Training to Serve online training (eTTS)
- Group 2: Training to Serve (TTS) in person training
- Group 3: Waitlist control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger